Literature DB >> 2806491

Diagnostic labels applied to model case histories of chronic airflow obstruction. Responses to a questionnaire in 11 North American and Western European countries.

N B Pride1, P Vermeire, L Allegra.   

Abstract

In Canada, USA and 9 Western European Countries, 121 respiratory physicians responded to an English language questionnaire asking them to state how they would investigate, treat and label four model patients, chosen to represent well-recognized patterns of clinical features of chronic airflow obstruction. Selection of further investigations appeared to be determined more by the probable diagnostic label than by the need to define selected characteristics in the whole range of such patients. Differences in recommended treatment between countries were less than others have reported for the treatment of asthma. Analysis of the diagnostic labels showed: the classic terms asthma, chronic bronchitis, emphysema still predominated in clinical practice and were considered to be better defined entities than any of the many terms introduced to describe chronic airflow obstruction in the last 30 yrs; the term chronic bronchitis was a source of confusion unless qualified to indicate presence or absence of obstruction; the use of combination terms such as chronic asthmatic bronchitis and chronic obstructive bronchitis showed large differences between countries; there were few differences related to national language. The implications of these findings are discussed.

Entities:  

Mesh:

Year:  1989        PMID: 2806491

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  6 in total

Review 1.  Dyspnoea in the elderly: a clinical approach to diagnosis.

Authors:  J C Yernault
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 2.  Pulmonary rehabilitation in chronic respiratory insufficiency. 1. Pulmonary rehabilitation in perspective: historical roots, present status, and future projections.

Authors:  T L Petty
Journal:  Thorax       Date:  1993-08       Impact factor: 9.139

3.  Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group.

Authors:  P L Brand; P H Quanjer; D S Postma; H A Kerstjens; G H Koëter; P N Dekhuijzen; H J Sluiter
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

4.  Risk factors for chronic obstructive pulmonary disease in a north Italian rural area.

Authors:  G Viegi; L Carrozzi; F Di Pede; S Baldacci; M Pedreschi; P Modena; P Paoletti
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

5.  Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.

Authors:  D C Weir; P S Burge
Journal:  Thorax       Date:  1993-04       Impact factor: 9.139

6.  Worldwide patterns of bronchodilator responsiveness: results from the Burden of Obstructive Lung Disease study.

Authors:  Wan C Tan; William M Vollmer; Bernd Lamprecht; David M Mannino; Anamika Jithoo; Ewa Nizankowska-Mogilnicka; Filip Mejza; Thorarinn Gislason; Peter G J Burney; A Sonia Buist
Journal:  Thorax       Date:  2012-04-29       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.